HLA-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice

Journal of Clinical Investigation

Volumn 105, Issue 7, 2000, Pages 977-984

  Kawamura, Kazuyuki ^a   Yamamura, Takashi ^a   Yokoyama, Kazumasa ^a   Chui, De Hua ^a   Fukui, Yoshinori ^b   Sasazuki, Takehiko ^b   Inoko, Hidetoshi ^c   David, Chella S ^d   Tabira, Takeshi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA DR2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEOLIPID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; FEMALE; HELPER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 0034128717     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8407     Document Type: Article

References (33)

1. Martin, R., McFarland, H.H., and McFarlin, D.E. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153-187.
2. Hafler, D.A., and Weiner, H.L. 1995. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144:75-107.
3. Zhang, J.W., et al. 1994. Increased frequency of in interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973-984.
4. Allegretta, M., Nicklas, J.A., Sriram, S., and Albertini, R.J. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science. 247:718-721.
5. Trotter, J.L., et al. 1997. HPRT mutant T-cell lines from multiple sclerosis patients recognize myelin proteolipid peprides. J. Neuroimmunol. 75:95-103.
6. Ohashi, T., et al. 1995. Analysis of proteolipid protein (PLP) in multiple sclerosis: identification of PLP95-116 as an HLA-DR2,w15-associated determinant. Int. Immunol. 7:1771-1778.
7. Oksenberg, J.R., et al. 1993. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:68-70.
8. Kondo, T., et al. 1995. TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences. Int. Immunol. 8:123-130.
9. Ota, K., et al. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
10. Trotter, J.L., et al. 1998. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects. J. Neuroimmunol. 84:172-178.
11. Moalem, G., et al. 1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:49-55.
12. Kerschensteiner, M., et al. 1999. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189:865-870.
13. Besser, M., and Wank, R. 1999. Clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J. Immunol. 162:6303-6306.
14. Shinkai, Y., et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:855-867.
15. Fukui, Y., et al. 1993. T-cell repertoire in a strain of transgenic C57BL/6 mice with the HLA-DRA gene on the X-chromosome. Immunogenetics. 37:204-211.
16. Gonzalez-Gay, M.A., et al. 1996. Human leukocyte antigen-DRB1* 1502 (UR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum. Immunol. 50:54-60
17. 0 mutant mice. Cell. 58:583-594.
18. Zhang, B.N., Yamamura, T., Kondo, T., Fujiwara, M., and Tabira, T. 1997. Regulation of experimental autoimmune encephalitis by natural killer (NK) cells. J. Exp. Med. 186:1677-1687.
19. + T cells in multiple sclerosis. J. Immunol. 162:1811-1817.
20. Tuohy, V.K. 1994. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review. Neurochem. Res. 19:935-944.
21. Das, P., et al. 1997. HLA transgenic mice as humanized models of multiple sclerosis (MS): studies on EAE. Hum. Immunol. 55(Suppl. 1):4. (Abstr.)
22. Ito, K., et al. 1996. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183:2635-2644.
23. Olerup, O., and Hillert, J. 1991. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 38:1-15.
24. Yao, D.L., et al. 1994. Concentric sclerosis (Balo): morphmetric and in situ hybridization study of lesions in six patients. Ann. Neurol. 35:18-30.
25. Marsh, S.G.E., and Bodmer, J.G. 1993. HLA class II nucleotide sequences, 1992. Immunogenetics. 37:79-94.
26. Wucherpfennig, K.W., and Strominger, J.L. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1597-1601.
27. Smith, K.J., Pyrdol, J., Gauthier, L., Wiley, D.C., and Wucherpfennig, K.W. 1998. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J. Exp. Med. 188:1511-1520.
28. Wucherpfennig, K.W., and Strominger, J.L. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
29. Sobel, R.A., Greer, J.M., and Kuchroo, V.K. 1994, Minireview: autoimmune responses to myelin proteolipid protein. Neurochem. Res. 19:915-921.
30. Endoh, M., et al. 1986. DM-20, a proteolipid apoprotein, is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J. Immunol. 137:3832-3835.
31. Greer, J.M., et al. 1996. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156:371-379.
32. Kojima, K., et al. 1994. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for S100β molecule, a calcium binding protein of astroglia. J. Exp. Med. 180:817-829.
33. Kidd, D., et al. 1999. Cortical lesions in multiple sclerosis. Brain. 122:17-26.